Home › Funds › Vivo Capital, LLC › DTIL

Vivo Capital, LLC position in DTIL

Precision Biosciences Inc · Health Care

Vivo Capital, LLC reported holding 4,675 shares of DTIL (Precision Biosciences Inc) in its Q3 2026 13F filing — a position valued at US$29K, representing 0.00% of its reported portfolio and ranking #48 among its reported holdings. Vivo Capital, LLC has disclosed DTIL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.67K sh
Reported value held$29.27K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's DTIL position evolved

Vivo Capital, LLC first disclosed a stake in DTIL in Q3 2023 at 140,255 shares (US$48K). The position peaked in Q1 2024 at 4,675 shares, worth US$63K. Across 13 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 4,675 shares valued at US$29K. Notable position changes include a 97% trim in Q1 2024 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 140.25K $47.87K New
Q4 2023 140.25K $51.19K Hold
Q1 2024 4.67K $63.40K Reduce
Q2 2024 4.67K $45.49K Hold
Q3 2024 4.67K $41.89K Hold
Q4 2024 4.67K $17.81K Hold
Q1 2025 4.67K $22.30K Hold
Q2 2025 4.67K $19.64K Hold
Q3 2025 4.67K $25.81K Hold
Q4 2025 4.67K $19.45K Hold
Q1 2026 4.67K $25.71K Hold
Q2 2026 4.67K $36.75K Hold
Q3 2026 4.67K $29.27K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DTIL and 13F data

DTIL (Precision Biosciences Inc) is a Health Care company. 50 other funds we track also report a position in DTIL — the largest reported positions include Bleichroeder LP (US$12.6M), Octagon Capital Advisors LP (US$10.6M), Lynx1 Capital Management LP (US$7.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DTIL

All DTIL fund holders →

FAQ

How long has Vivo Capital, LLC held DTIL?

Vivo Capital, LLC has disclosed DTIL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vivo Capital, LLC's current position in DTIL?

As of Q3 2026, Vivo Capital, LLC holds 4.67K shares of DTIL (Precision Biosciences Inc), valued at $29.27K, representing 0.00% of its reported portfolio and ranking #48.

Has Vivo Capital, LLC been buying or selling DTIL?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in DTIL. The position peaked in Q1 2024 at 4.67K shares.

Which other funds hold DTIL?

Other major institutional holders of DTIL include Bleichroeder LP, Octagon Capital Advisors LP, Lynx1 Capital Management LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.